Liu Q, Jiang C-Y, Chen B-X, Zhao W, Meng D
Department of Obesity and Metabolism, Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Eur Rev Med Pharmacol Sci. 2015 Dec;19(23):4558-68.
To explore the association between high-sensitivity C-reactive protein (hs-CRP) concentration and diabetic nephropathy (DN).
We systematically searched Pubmed, Medline and Embase databases up to September, 2014 for the relevant studies. Heterogeneity across studies was evaluated by Cochran's Q test and I2 statistic. The standard mean difference (SMD) and the corresponding 95% confidence interval (CI) were combined to evaluate the effect size. Sensitivity analysis was also performed by omitting each study to evaluate the stability of the results. In addition, publication bias was tested by Egger's test.
A total of 11 studies containing 1 331 cases and 1 779 controls were included in this study. Significant heterogeneities were observed in our results. The result of meta-analysis showed that the hs-CRP concentrations in DN patients were significantly higher than that in controls of healthy people and diabetes mellitus (DM) patients without nephropathy. In addition, the hs-CRP concentration in macroalbuminuria (D3) group was significantly higher than that in microalbuminuria (D2) group and non-albuminuria group (D1). Sensitivity analysis revealed that the results were stable. As well, no publication bias was observed in our results.
We suggest that hs-CRP concentration can be an indicator of DN in DM patients.
探讨高敏C反应蛋白(hs-CRP)浓度与糖尿病肾病(DN)之间的关联。
我们系统检索了截至2014年9月的Pubmed、Medline和Embase数据库中的相关研究。通过Cochran's Q检验和I²统计量评估研究间的异质性。合并标准均数差(SMD)及相应的95%置信区间(CI)以评估效应大小。通过逐一剔除每项研究进行敏感性分析,以评估结果的稳定性。此外,采用Egger检验检测发表偏倚。
本研究共纳入11项研究,包含1331例病例和1779例对照。研究结果存在显著异质性。Meta分析结果显示,DN患者的hs-CRP浓度显著高于健康人和无肾病的糖尿病(DM)患者对照组。此外,大量蛋白尿(D3)组的hs-CRP浓度显著高于微量蛋白尿(D2)组和无蛋白尿组(D1)。敏感性分析显示结果稳定。同时,研究结果未观察到发表偏倚。
我们认为hs-CRP浓度可作为DM患者DN的一个指标。